{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:36:21Z","timestamp":1790487381233,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":204,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540721444","type":"print"},{"value":"9783540721468","type":"electronic"}],"license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008]]},"DOI":"10.1007\/978-3-540-72146-8_3","type":"book-chapter","created":{"date-parts":[[2007,11,20]],"date-time":"2007-11-20T07:15:10Z","timestamp":1195542910000},"page":"67-101","source":"Crossref","is-referenced-by-count":10,"title":["Human Monoclonal Antibody and Vaccine Approaches to Prevent Human Rabies"],"prefix":"10.1007","author":[{"given":"T.","family":"Nagarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott K.","family":"Dessain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. N.","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Thiagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. A.","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1099\/0022-1317-78-9-2319","volume":"78","author":"B Amengual","year":"1997","unstructured":"Amengual B, Whitby JE, King A, Cobo JS, Bourhy H (1997) Evolution of European bat lyssaviruses. J Gen Virol 78:2319\u20132328","journal-title":"J Gen Virol"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF02820173","volume":"58","author":"SC Arya","year":"1991","unstructured":"Arya SC (1991) Acquisition of spongiform encephalopathies in India through sheep-brain rabies vaccination. Indian J Pediatr 58:563\u2013565","journal-title":"Indian J Pediatr"},{"key":"3_CR3","first-page":"219","volume":"187","author":"MF Aubert","year":"1994","unstructured":"Aubert MF, Masson E, Artois M, Barrat J (1994) Oral wildlife rabies vaccination field trials in Europe, with recent emphasis on France. Curr Top Microbiol Immunol 187:219\u2013243","journal-title":"Curr Top Microbiol Immunol"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1128\/JVI.75.17.8096-8104.2001","volume":"75","author":"H Badrane","year":"2001","unstructured":"Badrane H, Tordo N (2001) Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders. J Virol 75:8096\u20138104","journal-title":"J Virol"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","volume":"75","author":"H Badrane","year":"2001","unstructured":"Badrane H, Bahloul C, Perrin P, Tordo N (2001) Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol 75:3268\u20133276","journal-title":"J Virol"},{"key":"3_CR6","first-page":"105","volume-title":"The natural history of rabies","author":"GM Baer","year":"1991","unstructured":"Baer GM, Lentz TL (1991) Rabies pathogenesis in the central nervous system. In: Baer GM (ed) The natural history of rabies. CRC Press, Boca Raton, pp 105\u2013120"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0264-410X(97)00204-1","volume":"16","author":"C Bahloul","year":"1998","unstructured":"Bahloul C, Jacob Y, Tordo N, Perrin P (1998) DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine 16:417\u2013425","journal-title":"Vaccine"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0264-410X(03)00568-1","volume":"22","author":"C Bahloul","year":"2003","unstructured":"Bahloul C, Ahmed SB, B\u2019Chir BI, Kharmachi H, Hayouni el A, Dellagi K (2003) Post-exposure therapy in mice against experimental rabies: a single injection of DNA vaccine is as effective as five injections of cell culture-derived vaccine. Vaccine 22:177\u2013184","journal-title":"Vaccine"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.vaccine.2005.09.016","volume":"24","author":"C Bahloul","year":"2006","unstructured":"Bahloul C, Taieb D, Diouani MF, Ahmed SB, Chtourou Y, B\u2019Chir BI, Kharmachi H, Dellagi K (2006) Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions. Vaccine 24:1063\u20131072","journal-title":"Vaccine"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1073\/pnas.031419998","volume":"98","author":"H Bakker","year":"2001","unstructured":"Bakker H, Bardor M, Molthoff JW, Gomord V, Elbers I, Stevens LH, Jordi W, Lommen A, Faye L, Lerouge P, Bosch D (2001) Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci U S A 98:2899\u20132904","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR11","first-page":"747","volume":"13","author":"M Balthazard","year":"1955","unstructured":"Balthazard M, Bhamanyar M, Ghodssi M, Sabeti A, Gajdusek C, Rouzbehi E (1955) Essai pratique du serum antirabique chez les mordus par loups enrages. Bull World Health Organ 13:747\u2013772","journal-title":"Bull World Health Organ"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-1157(84)80019-0","volume":"12","author":"R Barth","year":"1984","unstructured":"Barth R, Gruschkau H, Bijok U, Hilfenhaus J, Hinz J, Milcke L, Moser H, Jaeger O, Ronneberger H, Weinmann E (1984) A new inactivated tissue culture rabies vaccine for use in man. Evaluation of PCEC-vaccine by laboratory tests. J Biol Stand 12:29\u201346","journal-title":"J Biol Stand"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.virusres.2005.03.006","volume":"111","author":"A Belotto","year":"2005","unstructured":"Belotto A, Leanes LF, Schneider MC, Tamayo H, Correa E (2005) Overview of rabies in the Americas. Virus Res 111:5\u201312","journal-title":"Virus Res"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/JVI.65.8.4198-4203.1991","volume":"65","author":"A Benmansour","year":"1991","unstructured":"Benmansour A, Leblois H, Coulon P, Tuffereau C, Gaudin Y, Flamand A, Lafay F (1991) Antigenicity of rabies virus glycoprotein. J Virol 65:4198\u20134203","journal-title":"J Virol"},{"key":"3_CR15","unstructured":"Bhatia R, Ichhpujani RL, Madhusudana SN, Hemachudha T (2004) Rabies in South and Southeast Asia. In: Program and abstracts of the WHO Expert Consultation on Rabies, Geneva"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1089\/104303401753153965","volume":"12","author":"S Biswas","year":"2001","unstructured":"Biswas S, Reddy GS, Srinivasan VA, Rangarajan PN (2001) Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine. Hum Gene Ther 12:1917\u20131922","journal-title":"Hum Gene Ther"},{"issue":"4","key":"3_CR17","doi-asserted-by":"crossref","first-page":"S606","DOI":"10.1093\/clinids\/10.Supplement_4.S606","volume":"10","author":"J Blancou","year":"1988","unstructured":"Blancou J (1988) Ecology and epidemiology of fox rabies. Rev Infect Dis 10 [Suppl 4]:S606\u2013S609","journal-title":"Rev Infect Dis"},{"key":"3_CR18","first-page":"883","volume":"64","author":"K Bogel","year":"1986","unstructured":"Bogel K, Motschwiller E (1986) Incidence of rabies and post-exposure treatment in developing countries. Bull World Health Organ 64:883\u2013887","journal-title":"Bull World Health Organ"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/JCM.30.9.2419-2426.1992","volume":"30","author":"H Bourhy","year":"1992","unstructured":"Bourhy H, Kissi B, Lafon M, Sacramento D, Tordo N (1992) Antigenic and molecular characterization of bat rabies virus in Europe. J Clin Microbiol 30:2419\u20132426","journal-title":"J Clin Microbiol"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/viro.1993.1236","volume":"194","author":"H Bourhy","year":"1993","unstructured":"Bourhy H, Kissi B, Tordo N (1993) Molecular diversity of the Lyssavirus genus. Virology 194:70\u201381","journal-title":"Virology"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1517\/14712598.4.3.387","volume":"4","author":"S Bregenholt","year":"2004","unstructured":"Bregenholt S, Haurum J (2004) Pathogen-specific recombinant human polyclonal antibodies: biodefence applications. Expert Opin Biol Ther 4:387\u2013396","journal-title":"Expert Opin Biol Ther"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd984","volume":"2","author":"OH Brekke","year":"2003","unstructured":"Brekke OH, Sandlie I (2003) Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2:52\u201362","journal-title":"Nat Rev Drug Discov"},{"key":"3_CR23","first-page":"693","volume":"78","author":"DJ Briggs","year":"2000","unstructured":"Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C (2000) Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 78:693\u2013698","journal-title":"Bull World Health Organ"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","volume":"23","author":"SM Brookes","year":"2005","unstructured":"Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR (2005) Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine 23:4101\u20134109","journal-title":"Vaccine"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(86)90032-3","volume":"89","author":"WL Carroll","year":"1986","unstructured":"Carroll WL, Thielemans K, Dilley J, Levy R (1986) Mouse x human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods 89:61\u201372","journal-title":"J Immunol Methods"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","volume":"8","author":"A Casadevall","year":"2002","unstructured":"Casadevall A (2002) Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis 8:833\u2013841","journal-title":"Emerg Infect Dis"},{"key":"3_CR27","unstructured":"Center for Biologics Evaluation and Research (1995) Guidance for industry: considerations for plasmid DNA vaccines for infectious disease indications. http:\/\/www.fda.gov\/cber\/gdlns\/plasdnavac.pdf . Cited 18 May 2007"},{"key":"3_CR28","first-page":"1","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","unstructured":"Centers for Disease Control and Prevention (1999) Human rabies prevention\u2014United States, 1999. Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 48:1\u201321","journal-title":"MMWR Recomm Rep"},{"key":"3_CR29","first-page":"287","volume":"53","author":"Centers for Disease Control","year":"2004","unstructured":"Centers for Disease Control (2004) Manufacturer\u2019s recall of human rabies vaccine. MMWR Dispatch 53:287\u2013289","journal-title":"MMWR Dispatch"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(99)00223-9","volume":"235","author":"JM Champion","year":"2000","unstructured":"Champion JM, Kean RB, Rupprecht CE, Notkins AL, Koprowski H, Dietzschold B, Hooper DC (2000) The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. J Immunol Methods 235:81\u201390","journal-title":"J Immunol Methods"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1128\/JVI.66.11.6714-6720.1992","volume":"66","author":"SC Cheung","year":"1992","unstructured":"Cheung SC, Dietzschold B, Koprowski H, Notkins AL, Rando RF (1992) A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus. J Virol 66:6714\u20136720","journal-title":"J Virol"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"13666","DOI":"10.1073\/pnas.240326697","volume":"97","author":"JE Childs","year":"2000","unstructured":"Childs JE, Curns AT, Dey ME, Real LA, Feinstein L, Bjornstad ON, Krebs JW (2000) Predicting the local dynamics of epizootic rabies among raccoons in the United States. Proc Natl Acad Sci U S A 97:13666\u201313671","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR33","volume-title":"Control of communicable diseases manual","author":"J Chin","year":"2000","unstructured":"Chin J (2000) Control of communicable diseases manual. APHA, Washington, DC"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0140-6736(90)90488-Q","volume":"335","author":"S Chutivongse","year":"1990","unstructured":"Chutivongse S, Wilde H, Supich C, Baer GM, Fishbein DB (1990) Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 335:896\u2013898","journal-title":"Lancet"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0264-410X(91)90244-Z","volume":"9","author":"S Chutivongse","year":"1991","unstructured":"Chutivongse S, Wilde H, Fishbein DB, Baer GM, Hemachudha T (1991) One-year study of the 2\u20131-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine. Vaccine 9:573\u2013576","journal-title":"Vaccine"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0264-410X(02)00778-8","volume":"21","author":"S Cleaveland","year":"2003","unstructured":"Cleaveland S, Kaare M, Tiringa P, Mlengeya T, Barrat J (2003) A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries. Vaccine 21:1965\u20131973","journal-title":"Vaccine"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","volume":"212","author":"F Cliquet","year":"1998","unstructured":"Cliquet F, Aubert M, Sagne L (1998) Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods 212:79\u201387","journal-title":"J Immunol Methods"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3201\/eid1001.020774","volume":"10","author":"PG Coleman","year":"2004","unstructured":"Coleman PG, Fevre EM, Cleaveland S (2004) Estimating the public health impact of rabies. Emerg Infect Dis 10:140\u2013142","journal-title":"Emerg Infect Dis"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4269\/ajtmh.2003.69.155","volume":"69","author":"JL Corn","year":"2003","unstructured":"Corn JL, Mendez JR, Catalan EE (2003) Evaluation of baits for delivery of oral rabies vaccine to dogs in Guatemala. Am J Trop Med Hyg 69:155\u2013158","journal-title":"Am J Trop Med Hyg"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","volume":"16","author":"JH Cox","year":"1977","unstructured":"Cox JH, Dietzschold B, Schneider LG (1977) Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun 16:754\u2013759","journal-title":"Infect Immun"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1360-1385(01)01922-7","volume":"6","author":"H Daniell","year":"2001","unstructured":"Daniell H, Streatfield SJ, Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6:219\u2013226","journal-title":"Trends Plant Sci"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/vr.155.16.496","volume":"155","author":"D David","year":"2004","unstructured":"David D, Yakobson BA, Gershkovich L, Gayer S (2004) Tracing the regional source of rabies infection in an Israeli dog by viral analysis. Vet Rec 155:496\u2013497","journal-title":"Vet Rec"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","volume":"58","author":"J Kruif de","year":"2007","unstructured":"de Kruif J, Bakker AB, Marissen WE, Kramer RA, Throsby M, Rupprecht CE, Goudsmit J (2007) A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis. Annu Rev Med 58:359\u2013368","journal-title":"Annu Rev Med"},{"key":"3_CR44","first-page":"477","volume":"28","author":"DJ Dean","year":"1963","unstructured":"Dean DJ, Baer GM, Thompson WR (1963) Studies on the local treatment of rabies-infected wounds. Bull World Health Organ 28:477\u2013486","journal-title":"Bull World Health Organ"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/153685902317401735","volume":"21","author":"B Dietzschold","year":"2002","unstructured":"Dietzschold B, Schnell MJ (2002) New approaches to the development of live attenuated rabies vaccines. Hybrid Hybridomics 21:129\u2013134","journal-title":"Hybrid Hybridomics"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0042-6822(87)90167-X","volume":"161","author":"B Dietzschold","year":"1987","unstructured":"Dietzschold B, Tollis M, Lafon M, Wunner WH, Koprowski H (1987) Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. Virology 161:29\u201336","journal-title":"Virology"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/JVI.64.6.3087-3090.1990","volume":"64","author":"B Dietzschold","year":"1990","unstructured":"Dietzschold B, Gore M, Casali P, Ueki Y, Rupprecht CE, Notkins AL, Koprowski H (1990) Biological characterization of human monoclonal antibodies to rabies virus. J Virol 64: 3087\u20133090","journal-title":"J Virol"},{"key":"3_CR48","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1073\/pnas.89.15.7252","volume":"89","author":"B Dietzschold","year":"1992","unstructured":"Dietzschold B, Kao M, Zheng YM, Chen ZY, Maul G, Fu ZF, Rupprecht CE, Koprowski H (1992) Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc Natl Acad Sci U S A 89:7252\u20137256","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1586\/14760584.2.3.399","volume":"2","author":"B Dietzschold","year":"2003","unstructured":"Dietzschold B, Faber M, Schnell MJ (2003) New approaches to the prevention and eradication of rabies. Expert Rev Vaccines 2:399\u2013406","journal-title":"Expert Rev Vaccines"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0264-410X(89)90152-7","volume":"7","author":"DW Dreesen","year":"1989","unstructured":"Dreesen DW, Fishbein DB, Kemp DT, Brown J (1989) Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine 7:397\u2013400","journal-title":"Vaccine"},{"key":"3_CR51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/hyb.1991.10.547","volume":"10","author":"K Enssle","year":"1991","unstructured":"Enssle K, Kurrle R, Kohler R, Muller H, Kanzy EJ, Hilfenhaus J, Seiler FR (1991) A rabies-specific human monoclonal antibody that protects mice against lethal rabies. Hybridoma 10:547\u2013556","journal-title":"Hybridoma"},{"key":"3_CR52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virusres.2005.03.015","volume":"111","author":"HC Ertl","year":"2005","unstructured":"Ertl HC (2005) Immunological insights from genetic vaccines. Virus Res 111:89\u201392","journal-title":"Virus Res"},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/vim.1996.9.1","volume":"9","author":"HC Ertl","year":"1996","unstructured":"Ertl HC, Xiang ZQ (1996) Genetic immunization. Viral Immunol 9:1\u20139","journal-title":"Viral Immunol"},{"key":"3_CR54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-1-23","volume":"1","author":"R Estrada","year":"2001","unstructured":"Estrada R, Vos A, De Leon R, Mueller T (2001) Field trial with oral vaccination of dogs against rabies in the Philippines. BMC Infect Dis 1:23","journal-title":"BMC Infect Dis"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-3148.2001.00288.x","volume":"11","author":"A Farrugia","year":"2001","unstructured":"Farrugia A, Poulis P (2001) Intravenous immunoglobulin: regulatory perspectives on use and supply. Transfus Med 11:63\u201374","journal-title":"Transfus Med"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0264-410X(96)00312-X","volume":"15","author":"ZF Fu","year":"1997","unstructured":"Fu ZF (1997) Rabies and rabies research: past, present and future. Vaccine 15 Suppl:S20\u2013S24","journal-title":"Vaccine"},{"key":"3_CR57","first-page":"3","volume":"8","author":"E Fuenzalida","year":"1955","unstructured":"Fuenzalida E, Palacios R (1955) An improved method for preparation of rabies vaccine [in Spanish]. Biol Inst Bacteriol Chile 8:3\u201310","journal-title":"Biol Inst Bacteriol Chile"},{"key":"3_CR58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1006\/excr.1998.4384","volume":"247","author":"A Funaro","year":"1999","unstructured":"Funaro A, Horenstein AL, Ghisolfi G, Bussolati B, Bartorelli A, Bussolati G (1999) Identification of a 220-kDa membrane tumor-associated antigen by human anti-UK114 monoclonal antibodies selected from the immunoglobulin repertoire of a cancer patient. Exp Cell Res 247:441\u2013450","journal-title":"Exp Cell Res"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.03.219","volume":"345","author":"LS Girard","year":"2006","unstructured":"Girard LS, Fabis MJ, Bastin M, Courtois D, Petiard V, Koprowski H (2006) Expression of a human anti-rabies virus monoclonal antibody in tobacco cell culture. Biochem Biophys Res Commun 345:602\u2013607","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR60","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","volume":"193","author":"J Goudsmit","year":"2006","unstructured":"Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, Rice AB, Kruif J, Dietzschold B, Bakker AB, Rupprecht CE (2006) Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J Infect Dis 193:796\u2013801","journal-title":"J Infect Dis"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0264-410X(94)90093-0","volume":"12","author":"N Haddad","year":"1994","unstructured":"Haddad N, Ben Khelifa R, Matter H, Kharmachi H, Aubert MF, Wandeler A, Blancou J (1994) Assay of oral vaccination of dogs against rabies in Tunisia with the vaccinal strain SADBern. Vaccine 12:307\u2013309","journal-title":"Vaccine"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0264-410X(00)00516-8","volume":"19","author":"CA Hanlon","year":"2001","unstructured":"Hanlon CA, Niezgoda M, Morrill PA, Rupprecht CE (2001) The incurable wound revisited: progress in human rabies prevention? Vaccine 19:2273\u20132279","journal-title":"Vaccine"},{"key":"3_CR63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0966-842X(96)10048-2","volume":"4","author":"DE Hassett","year":"1996","unstructured":"Hassett DE, Whitton JL (1996) DNA immunization. Trends Microbiol 4:307\u2013312","journal-title":"Trends Microbiol"},{"key":"3_CR64","doi-asserted-by":"crossref","first-page":"A266","DOI":"10.1093\/infdis\/133.Supplement_2.A266","volume":"133","author":"MA Hattwick","year":"1976","unstructured":"Hattwick MA, Corey L, Creech WB (1976) Clinical use of human globulin immune to rabies virus. J Infect Dis 133 Suppl:A266\u2013272","journal-title":"J Infect Dis"},{"key":"3_CR65","first-page":"404","volume":"8","author":"J Haurum","year":"2005","unstructured":"Haurum J, Bregenholt S (2005) Recombinant polyclonal antibodies: therapeutic antibody technologies come full circle. IDrugs 8:404\u2013409","journal-title":"IDrugs"},{"key":"3_CR66","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/nbt1027","volume":"22","author":"S Hellwig","year":"2004","unstructured":"Hellwig S, Drossard J, Twyman RM, Fischer R (2004) Plant cell cultures for the production of recombinant proteins. Nat Biotechnol 22:1415\u20131422","journal-title":"Nat Biotechnol"},{"key":"3_CR67","first-page":"383","volume-title":"Viral disease","author":"T Hemachudha","year":"1989","unstructured":"Hemachudha T (1989) Rabies. In: Vinken PJ, Bruyn GW, Klawans HL, McKendall RR (eds) Viral disease. Elsevier, Amsterdam, pp 383\u2013404"},{"key":"3_CR68","first-page":"121","volume":"187","author":"T Hemachudha","year":"1994","unstructured":"Hemachudha T (1994) Human rabies: clinical aspects, pathogenesis, and potential therapy. Curr Top Microbiol Immunol 187:121\u2013143","journal-title":"Curr Top Microbiol Immunol"},{"key":"3_CR69","first-page":"401","volume-title":"Infectious diseases of the nervous system","author":"T Hemachudha","year":"2000","unstructured":"Hemachudha T, Mitrabhakdi E (2000) Rabies. In: Davis LE, Kennedy PGE (eds) Infectious diseases of the nervous system. Butterworth Heinemann, Oxford, pp 401\u2013444"},{"key":"3_CR70","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00019052-199706000-00016","volume":"10","author":"T Hemachudha","year":"1997","unstructured":"Hemachudha T, Phuapradit P (1997) Rabies. Curr Opin Neurol 10:260\u2013267","journal-title":"Curr Opin Neurol"},{"key":"3_CR71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1212\/WNL.37.4.550","volume":"37","author":"T Hemachudha","year":"1987","unstructured":"Hemachudha T, Phanuphak P, Johnson RT, Griffin DE, Ratanavongsiri J, Siriprasomsup W (1987) Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies. Neurology 37:550\u2013556","journal-title":"Neurology"},{"key":"3_CR72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1474-4422(02)00041-8","volume":"1","author":"T Hemachudha","year":"2002","unstructured":"Hemachudha T, Laothamatas J, Rupprecht CE (2002) Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 1:101\u2013109","journal-title":"Lancet Neurol"},{"key":"3_CR73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/342076a0","volume":"342","author":"A Hiatt","year":"1989","unstructured":"Hiatt A, Cafferkey R, Bowdish K (1989) Production of antibodies in transgenic plants. Nature 342:76\u201378","journal-title":"Nature"},{"key":"3_CR74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/viro.2001.1271","volume":"292","author":"EC Holmes","year":"2002","unstructured":"Holmes EC, Woelk CH, Kassis R, Bourhy H (2002) Genetic constraints and the adaptive evolution of rabies virus in nature. Virology 292:247\u2013257","journal-title":"Virology"},{"key":"3_CR75","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1128\/JVI.72.5.3711-3719.1998","volume":"72","author":"DC Hooper","year":"1998","unstructured":"Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B (1998) Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72:3711\u20133719","journal-title":"J Virol"},{"key":"3_CR76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-2452(97)83529-5","volume":"95","author":"PT Hooper","year":"1997","unstructured":"Hooper PT, Lunt RA, Gould AR, Samaratunga H, Hyatt AD, Gleeson LJ, Rodwell BJ, Rupprecht CE, Smith JS, Murray PK (1997) A new lyssavirus\u2014the first endemic rabies-related virus recognized in Australia. Bull Inst Pasteur 95:209\u2013218","journal-title":"Bull Inst Pasteur"},{"key":"3_CR77","first-page":"212","volume-title":"Proceedings of the fourth international symposium on rabies control in Asia","author":"RL Ichhpujani","year":"2001","unstructured":"Ichhpujani RL, Bhardwaj M, Chhabra M, Datta KK (2001) Rabies in humans in India. In: Dodet B, Meslin FX, Haseltine E (eds) Proceedings of the fourth international symposium on rabies control in Asia. John Libbey Eurotext, London, pp 212\u2013213"},{"key":"3_CR78","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1386-6532(02)00048-3","volume":"26","author":"M Ito","year":"2003","unstructured":"Ito M, Itou T, Shoji Y, Sakai T, Ito FH, Arai YT, Takasaki T, Kurane I (2003) Discrimination between dog-related and vampire bat-related rabies viruses in Brazil by strain-specific reverse transcriptase-polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Virol 26:317\u2013330","journal-title":"J Clin Virol"},{"key":"3_CR79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","volume":"73","author":"C Jallet","year":"1999","unstructured":"Jallet C, Jacob Y, Bahloul C, Drings A, Desmezieres E, Tordo N, Perrin P (1999) Chimeric lyssavirus glycoproteins with increased immunological potential. J Virol 73:225\u2013233","journal-title":"J Virol"},{"issue":"4","key":"3_CR80","doi-asserted-by":"crossref","first-page":"S620","DOI":"10.1093\/clinids\/10.Supplement_4.S620","volume":"10","author":"SR Jenkins","year":"1988","unstructured":"Jenkins SR, Perry BD, Winkler WG (1988) Ecology and epidemiology of raccoon rabies. Rev Infect Dis 10 [Suppl 4]:S620\u2013S625","journal-title":"Rev Infect Dis"},{"key":"3_CR81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2460\/javma.2004.224.216","volume":"224","author":"SR Jenkins","year":"2004","unstructured":"Jenkins SR, Auslander M, Conti L, Leslie MJ, Sorhage FE, Sun B (2004) Compendium of animal rabies prevention and control, 2004. J Am Vet Med Assoc 224:216\u2013222","journal-title":"J Am Vet Med Assoc"},{"key":"3_CR82","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1016\/j.vaccine.2006.03.012","volume":"24","author":"H Kallel","year":"2006","unstructured":"Kallel H, Diouani MF, Loukil H, Trabelsi K, Snoussi MA, Majoul S, Rourou S, Dellagi K (2006) Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine. Vaccine 24:4856\u20134862","journal-title":"Vaccine"},{"key":"3_CR83","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0264-410X(95)00213-K","volume":"14","author":"P Khawplod","year":"1996","unstructured":"Khawplod P, Wilde H, Chomchey P, Benjavongkulchai M, Yenmuang W, Chaiyabutr N, Sitprija V (1996) What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously? Vaccine 14:389\u2013391","journal-title":"Vaccine"},{"key":"3_CR84","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijid.2005.05.010","volume":"10","author":"B Kilic","year":"2006","unstructured":"Kilic B, Unal B, Semin S, Konakci SK (2006) An important public health problem: rabies suspected bites and post-exposure prophylaxis in a health district in Turkey. Int J Infect Dis 10:248\u2013254","journal-title":"Int J Infect Dis"},{"key":"3_CR85","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5877(99)00114-2","volume":"44","author":"PM Kitala","year":"2000","unstructured":"Kitala PM, McDermott JJ, Kyule MN, Gathuma JM (2000) Community-based active surveillance for rabies in Machakos District, Kenya. Prev Vet Med 44:73\u201385","journal-title":"Prev Vet Med"},{"key":"3_CR86","first-page":"360","volume":"83","author":"DL Knobel","year":"2005","unstructured":"Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, Miranda ME, Shaw A, Zinsstag J, Meslin FX (2005) Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83:360\u2013368","journal-title":"Bull World Health Organ"},{"key":"3_CR87","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1073\/pnas.0832472100","volume":"100","author":"K Ko","year":"2003","unstructured":"Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, Spitsin S, Hanlon CA, Rupprecht C, Dietzschold B, Golovkin M, Koprowski H (2003) Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci U S A 100:8013\u20138018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR88","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9343(50)90224-5","volume":"8","author":"H Koprowski","year":"1950","unstructured":"Koprowski H, Van Der Scheer J, Black J (1950) Use of hyperimmune anti-rabies serum concentrates in experimental rabies. Am J Med 8:412\u2013420","journal-title":"Am J Med"},{"key":"3_CR89","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/978-3-642-70060-6_4","volume-title":"Rabies in the tropics","author":"H Koprowski","year":"1985","unstructured":"Koprowski H, Wiktor T, Abelseth M (1985) Cross-reactivity and cross-protection: rabies variants and rabies-related viruses. In: Kuwert E, Merieux C, Koprowski H, Bogel K (eds) Rabies in the tropics. Springer-Verlag, Berlin Heidelberg New York, pp 30\u201339"},{"key":"3_CR90","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/eji.200526134","volume":"35","author":"RA Kramer","year":"2005","unstructured":"Kramer RA, Marissen WE, Goudsmit J, Visser TJ, Clijsters-Van der Horst M, Bakker AQ, de Jong M, Jongeneelen M, Thijsse S, Backus HH, Rice AB, Weldon WC, Rupprecht CE, Dietzschold B, Bakker AB, de Kruif J (2005) The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Eur J Immunol 35:2131\u20132145","journal-title":"Eur J Immunol"},{"key":"3_CR91","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2460\/javma.2005.227.1912","volume":"227","author":"JW Krebs","year":"2005","unstructured":"Krebs JW, Mandel EJ, Swerdlow DL, Rupprecht CE (2005) Rabies surveillance in the United States during 2004. J Am Vet Med Assoc 227:1912\u20131925","journal-title":"J Am Vet Med Assoc"},{"key":"3_CR92","first-page":"443","volume":"70","author":"A Kureishi","year":"1992","unstructured":"Kureishi A, Xu LZ, Wu H, Stiver HG (1992) Rabies in China: recommendations for control. Bull World Health Organ 70:443\u2013450","journal-title":"Bull World Health Organ"},{"key":"3_CR93","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virusres.2005.03.008","volume":"111","author":"IV Kuzmin","year":"2005","unstructured":"Kuzmin IV, Hughes GJ, Botvinkin AD, Orciari LA, Rupprecht CE (2005) Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for Lyssavirus genotype definition. Virus Res 111:28\u201343","journal-title":"Virus Res"},{"key":"3_CR94","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1099\/0022-1317-71-8-1689","volume":"71","author":"M Lafon","year":"1990","unstructured":"Lafon M, Edelman L, Bouvet JP, Lafage M, Montchatre E (1990) Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein. J Gen Virol 71:1689\u20131696","journal-title":"J Gen Virol"},{"key":"3_CR95","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1389201003378843","volume":"1","author":"P Lerouge","year":"2000","unstructured":"Lerouge P, Bardor M, Pagny S, Gomord V, Faye L (2000) N-Glycosylation of recombinant pharmaceutical glycoproteins produced in transgenic plants: towards an humanisation of plant N-glycans. Curr Pharm Biotechnol 1:347\u2013354","journal-title":"Curr Pharm Biotechnol"},{"key":"3_CR96","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-1759(00)00322-7","volume":"247","author":"M Liang","year":"2001","unstructured":"Liang M, Dubel S, Li D, Queitsch I, Li W, Bautz EK (2001) Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. J Immunol Methods 247:119\u2013130","journal-title":"J Immunol Methods"},{"key":"3_CR97","first-page":"213","volume":"57","author":"G Libeau","year":"1984","unstructured":"Libeau G, Lafon M (1984) Production of monoclonal antibodies against the Pasteur (P.V.) strain of rabies virus: problems and results. Dev Biol Stand 57:213\u2013218","journal-title":"Dev Biol Stand"},{"key":"3_CR98","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/S0264-410X(00)00475-8","volume":"19","author":"DL Lodmell","year":"2001","unstructured":"Lodmell DL, Ewalt LC (2001) Post-exposure DNA vaccination protects mice against rabies virus. Vaccine 19:2468\u20132473","journal-title":"Vaccine"},{"key":"3_CR99","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0898-949","volume":"4","author":"DL Lodmell","year":"1998","unstructured":"Lodmell DL, Ray NB, Parnell MJ, Ewalt LC, Hanlon CA, Shaddock JH, Sanderlin DS, Rupprecht CE (1998) DNA immunization protects nonhuman primates against rabies virus. Nat Med 4:949\u2013952","journal-title":"Nat Med"},{"key":"3_CR100","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0264-410X(99)00352-7","volume":"18","author":"DL Lodmell","year":"2000","unstructured":"Lodmell DL, Ray NB, Ulrich JT, Ewalt LC (2000) DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL). Vaccine 18:1059\u20131066","journal-title":"Vaccine"},{"key":"3_CR101","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0264-410X(01)00392-9","volume":"20","author":"DL Lodmell","year":"2001","unstructured":"Lodmell DL, Parnell MJ, Bailey JR, Ewalt LC, Hanlon CA (2001) One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination. Vaccine 20:838\u2013844","journal-title":"Vaccine"},{"key":"3_CR102","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nm0598-601","volume":"4","author":"JK Ma","year":"1998","unstructured":"Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, Hein MB, Lehner T (1998) Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 4:601\u2013606","journal-title":"Nat Med"},{"key":"3_CR103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7589\/0090-3558-37.1.119","volume":"37","author":"CD MacInnes","year":"2001","unstructured":"MacInnes CD, Smith SM, Tinline RR, Ayers NR, Bachmann P, Ball DG, Calder LA, Crosgrey SJ, Fielding C, Hauschildt P, Honig JM, Johnston DH, Lawson KF, Nunan CP, Pedde MA, Pond B, Stewart RB, Voigt DR (2001) Elimination of rabies from red foxes in eastern Ontario. J Wildl Dis 37:119\u2013132","journal-title":"J Wildl Dis"},{"key":"3_CR104","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","volume":"79","author":"WE Marissen","year":"2005","unstructured":"Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters-van der Horst M, Visser TJ, Jongeneelen M, Thijsse S, Throsby M, de Kruif J, Rupprecht CE, Dietzschold B, Goudsmit J, Bakker AB (2005) Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol 79:4672\u20134678","journal-title":"J Virol"},{"key":"3_CR105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1201-9712(00)90114-0","volume":"4","author":"L Martinez","year":"2000","unstructured":"Martinez L (2000) Global infectious disease surveillance. Int J Infect Dis 4:222\u2013228","journal-title":"Int J Infect Dis"},{"key":"3_CR106","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/427700","volume":"40","author":"IS Matha","year":"2005","unstructured":"Matha IS, Salunke SR (2005) Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India. Clin Infect Dis 40:611\u2013613","journal-title":"Clin Infect Dis"},{"key":"3_CR107","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0025-5564(84)90063-4","volume":"72","author":"RM May","year":"1984","unstructured":"May RM, Anderson RM (1984) Spatial heterogeneity and the design of immunization programs. Math Biosci 72:83\u2013111","journal-title":"Math Biosci"},{"key":"3_CR108","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1439-0450.2003.00713.x","volume":"50","author":"F Mayen","year":"2003","unstructured":"Mayen F (2003) Haematophagous bats in Brazil, their role in rabies transmission, impact on public health, livestock industry and alternatives to an indiscriminate reduction of bat population. J Vet Med B Infect Dis Vet Public Health 50:469\u2013472","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"3_CR109","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/emj.2003.013805","volume":"22","author":"N McKay","year":"2005","unstructured":"McKay N, Wallis L (2005) Rabies: a review of UK management. Emerg Med J 22:316\u2013321","journal-title":"Emerg Med J"},{"key":"3_CR110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JVI.73.1.242-250.1999","volume":"73","author":"T Mebatsion","year":"1999","unstructured":"Mebatsion T, Weiland F, Conzelmann KK (1999) Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol 73:242\u2013250","journal-title":"J Virol"},{"key":"3_CR111","first-page":"221","volume-title":"Laboratory techniques in rabies","author":"FX Meslin","year":"1996","unstructured":"Meslin FX, Kaplan MM (1996) General considerations in the production and use of brain-tissue and purified chicken embryo rabies vaccines for human use. In: Meslin FX, Kaplan MM, koprowski H (eds) Laboratory techniques in rabies. WHO, Geneva, pp 221\u2013233"},{"key":"3_CR112","first-page":"1","volume":"187","author":"FX Meslin","year":"1994","unstructured":"Meslin FX, Fishbein DB, Matter HC (1994) Rationale and prospects for rabies elimination in developing countries. Curr Top Microbiol Immunol 187:1\u201326","journal-title":"Curr Top Microbiol Immunol"},{"key":"3_CR113","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/342387","volume":"35","author":"SL Messenger","year":"2002","unstructured":"Messenger SL, Smith JS, Rupprecht CE (2002) Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis 35:738\u2013747","journal-title":"Clin Infect Dis"},{"key":"3_CR114","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0950268897008601","volume":"120","author":"C Mitmoonpitak","year":"1998","unstructured":"Mitmoonpitak C, Tepsumethanon V, Wilde H (1998) Rabies in Thailand. Epidemiol Infect 120:165\u2013169","journal-title":"Epidemiol Infect"},{"key":"3_CR115","first-page":"37","volume":"55","author":"B Montagnon","year":"1983","unstructured":"Montagnon B, Vincent-Falquet JC, Fanget B (1983) Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results. Dev Biol Stand 55:37\u201342","journal-title":"Dev Biol Stand"},{"key":"3_CR116","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1073\/pnas.93.11.5653","volume":"93","author":"K Morimoto","year":"1996","unstructured":"Morimoto K, Patel M, Corisdeo S, Hooper DC, Fu ZF, Rupprecht CE, Koprowski H, Dietzschold B (1996) Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci U S A 93:5653\u20135658","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR117","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/S0264-410X(01)00064-0","volume":"19","author":"K Morimoto","year":"2001","unstructured":"Morimoto K, McGettigan JP, Foley HD, Hooper DC, Dietzschold B, Schnell MJ (2001a) Genetic engineering of live rabies vaccines. Vaccine 19:3543\u20133551","journal-title":"Vaccine"},{"key":"3_CR118","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0022-1759(01)00353-2","volume":"252","author":"K Morimoto","year":"2001","unstructured":"Morimoto K, Schnell MJ, Pulmanausahakul R, McGettigan JP, Foley HD, Faber M, Hooper DC, Dietzschold B (2001b) High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector. J Immunol Methods 252:199\u2013206","journal-title":"J Immunol Methods"},{"key":"3_CR119","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/bmj.331.7529.s255","volume":"331","author":"G Mudur","year":"2005","unstructured":"Mudur G (2005) Foreign visitors to India are unaware of rabies risk. BMJ 331:255","journal-title":"BMJ"},{"key":"3_CR120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0166-0934(97)00099-2","volume":"67","author":"BH Muller","year":"1997","unstructured":"Muller BH, Lafay F, Demangel C, Perrin P, Tordo N, Flamand A, Lafaye P, Guesdon JL (1997) Phage-displayed and soluble mouse scFv fragments neutralize rabies virus. J Virol Methods 67:221\u2013233","journal-title":"J Virol Methods"},{"key":"3_CR121","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/viro.2002.1492","volume":"298","author":"SA Nadin-Davis","year":"2002","unstructured":"Nadin-Davis SA, Abdel-Malik M, Armstrong J, Wandeler AI (2002) Lyssavirus P gene characterisation provides insights into the phylogeny of the genus and identifies structural similarities and diversity within the encoded phosphoprotein. Virology 298:286\u2013305","journal-title":"Virology"},{"key":"3_CR122","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1128\/JCM.00801-06","volume":"44","author":"T Nagarajan","year":"2006","unstructured":"Nagarajan T, Mohanasubramanian B, Seshagiri EV, Nagendrakumar SB, Saseendranath MR, Satyanarayana ML, Thiagarajan D, Rangarajan PN, Srinivasan VA (2006a) Molecular epidemiology of rabies virus isolates in India. J Clin Microbiol 44:3218\u20133224","journal-title":"J Clin Microbiol"},{"key":"3_CR123","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","volume":"34","author":"T Nagarajan","year":"2006","unstructured":"Nagarajan T, Reddy GS, Mohana Subramanian B, Rajalakshmi S, Thiagarajan D, Tordo N, Jallet C, Srinivasan VA (2006b) A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture. Biologicals 34:21\u201327","journal-title":"Biologicals"},{"key":"3_CR124","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virusres.2004.12.003","volume":"109","author":"LH Nel","year":"2005","unstructured":"Nel LH, Sabeta CT, von Teichman B, Jaftha JB, Rupprecht CE, Bingham J (2005) Mongoose rabies in southern Africa: a re-evaluation based on molecular epidemiology. Virus Res 109:165\u2013173","journal-title":"Virus Res"},{"key":"3_CR125","first-page":"271","volume-title":"Laboratory techniques in rabies","author":"KG Nicholson","year":"1996","unstructured":"Nicholson KG (1996) Cell-culture vaccines for human use: general considerations. In: Meslin FX, Kaplan MM, Koprowski H (eds) Laboratory techniques in rabies. WHO, Geneva, pp 271\u2013279"},{"key":"3_CR126","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1348-0421.2002.tb02714.x","volume":"46","author":"A Nishizono","year":"2002","unstructured":"Nishizono A, Mannen K, Elio-Villa LP, Tanaka S, Li KS, Mifune K, Arca BF, Cabanban A, Martinez B, Rodriguez A, Atienza VC, Camba R, Resontoc N (2002) Genetic analysis of rabies virus isolates in the Philippines. Microbiol Immunol 46:413\u2013417","journal-title":"Microbiol Immunol"},{"key":"3_CR127","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0022-1759(94)90051-5","volume":"168","author":"RJ Owens","year":"1994","unstructured":"Owens RJ, Young RJ (1994) The genetic engineering of monoclonal antibodies. J Immunol Methods 168:149\u2013165","journal-title":"J Immunol Methods"},{"key":"3_CR128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1086\/514931","volume":"27","author":"S Parviz","year":"1998","unstructured":"Parviz S, Luby S, Wilde H (1998) Postexposure treatment of rabies in Pakistan. Clin Infect Dis 27:751\u2013756","journal-title":"Clin Infect Dis"},{"key":"3_CR129","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/sj.gt.3300964","volume":"6","author":"S Pasquini","year":"1999","unstructured":"Pasquini S, Deng H, Reddy ST, Giles-Davis W, Ertl HC (1999) The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector. Gene Ther 6:1448\u20131455","journal-title":"Gene Ther"},{"key":"3_CR130","first-page":"252","volume":"113","author":"GR Patrick","year":"1998","unstructured":"Patrick GR, O\u2019Rourke KM (1998) Dog and cat bites: epidemiologic analyses suggest different prevention strategies. Public Health Rep 113:252\u2013257","journal-title":"Public Health Rep"},{"key":"3_CR131","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4038\/cmj.v45i2.8002","volume":"45","author":"MA Perera","year":"2000","unstructured":"Perera MA, Harischandra PA, Wimalaratne O, Damboragama SN (2000) Feasibility of canine oral rabies vaccination in Sri Lanka\u2014a preliminary report. Ceylon Med J 45:61\u201364","journal-title":"Ceylon Med J"},{"key":"3_CR132","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/0264-410X(94)00022-F","volume":"13","author":"P Perrin","year":"1995","unstructured":"Perrin P, Madhusudana S, Gontier-Jallet C, Petres S, Tordo N, Merten OW (1995) An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. Vaccine 13:1244\u20131250","journal-title":"Vaccine"},{"key":"3_CR133","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0264-410X(99)00247-9","volume":"18","author":"P Perrin","year":"1999","unstructured":"Perrin P, Jacob Y, Aguilar-Setien A, Loza-Rubio E, Jallet C, Desmezieres E, Aubert M, Cliquet F, Tordo N (1999) Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 18:479\u2013486","journal-title":"Vaccine"},{"key":"3_CR134","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cellimm.2003.08.006","volume":"224","author":"AR Pinto","year":"2003","unstructured":"Pinto AR, Reyes-Sandoval A, Ertl HC (2003) Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus. Cell Immunol 224:106\u2013113","journal-title":"Cell Immunol"},{"key":"3_CR135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/clinids\/2.3.433","volume":"2","author":"SA Plotkin","year":"1980","unstructured":"Plotkin SA (1980) Rabies vaccine prepared in human cell cultures: progress and perspectives. Rev Infect Dis 2:433\u2013448","journal-title":"Rev Infect Dis"},{"key":"3_CR136","first-page":"743","volume-title":"Vaccines","author":"SA Plotkin","year":"1999","unstructured":"Plotkin SA, Rupprecht CE, Koprowski H (1999) Rabies vaccine. In: Plotkin SA, Orenstein WA (eds) Vaccines. WB Saunders, Philadelphia, pp 743\u2013766"},{"key":"3_CR137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.62.1.1-7.1988","volume":"62","author":"C Prehaud","year":"1988","unstructured":"Prehaud C, Coulon P, LaFay F, Thiers C, Flamand A (1988) Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J Virol 62:1\u20137","journal-title":"J Virol"},{"key":"3_CR138","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","volume":"188","author":"M Prosniak","year":"2003","unstructured":"Prosniak M, Faber M, Hanlon CA, Rupprecht CE, Hooper DC, Dietzschold B (2003) Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J Infect Dis 188:53\u201356","journal-title":"J Infect Dis"},{"key":"3_CR139","first-page":"283","volume":"23","author":"BC Ramanna","year":"1991","unstructured":"Ramanna BC, Reddy GS, Srinivasan VA (1991) An outbreak of rabies in cattle and use of tissue culture rabies vaccine during the outbreak. J Commun Dis 23:283\u2013285","journal-title":"J Commun Dis"},{"key":"3_CR140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.virusres.2005.05.002","volume":"113","author":"A Rath","year":"2005","unstructured":"Rath A, Choudhury S, Batra D, Kapre SV, Rupprecht CE, Gupta SK (2005) DNA vaccine for rabies: relevance of the transmembrane domain of the glycoprotein in generating an antibody response. Virus Res 113:143\u2013152","journal-title":"Virus Res"},{"key":"3_CR141","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0264-410X(96)00281-2","volume":"15","author":"NB Ray","year":"1997","unstructured":"Ray NB, Ewalt LC, Lodmell DL (1997) Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine 15:892\u2013895","journal-title":"Vaccine"},{"key":"3_CR142","doi-asserted-by":"crossref","first-page":"12107","DOI":"10.1073\/pnas.0500057102","volume":"102","author":"LA Real","year":"2005","unstructured":"Real LA, Henderson JC, Biek R, Snaman J, Jack TL, Childs JE, Stahl E, Waller L, Tinline R, Nadin-Davis S (2005) Unifying the spatial population dynamics and molecular evolution of epidemic rabies virus. Proc Natl Acad Sci U S A 102:12107\u201312111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR143","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2460\/javma.1998.212.08.1198","volume":"212","author":"LD Rotz","year":"1998","unstructured":"Rotz LD, Hensley JA, Rupprecht CE, Childs JE (1998) Large-scale human exposures to rabid or presumed rabid animals in the United States: 22 cases (1990\u20131996). J Am Vet Med Assoc 212:1198\u20131200","journal-title":"J Am Vet Med Assoc"},{"key":"3_CR144","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","volume":"351","author":"CE Rupprecht","year":"2004","unstructured":"Rupprecht CE, Gibbons RV (2004) Clinical practice. Prophylaxis against rabies. N Engl J Med 351:2626\u20132635","journal-title":"N Engl J Med"},{"key":"3_CR145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7589\/0090-3558-26.1.99","volume":"26","author":"CE Rupprecht","year":"1990","unstructured":"Rupprecht CE, Charlton KM, Artois M, Casey GA, Webster WA, Campbell JB, Lawson KF, Schneider LG (1990) Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis). J Wildl Dis 26:99\u2013102","journal-title":"J Wildl Dis"},{"key":"3_CR146","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0264-410X(92)90065-R","volume":"10","author":"CE Rupprecht","year":"1992","unstructured":"Rupprecht CE, Hanlon CA, Cummins LB, Koprowski H (1992) Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine. Vaccine 10:368\u2013374","journal-title":"Vaccine"},{"key":"3_CR147","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","volume":"2","author":"CE Rupprecht","year":"2002","unstructured":"Rupprecht CE, Hanlon CA, Hemachudha T (2002) Rabies re-examined. Lancet Infect Dis 2:327\u2013343","journal-title":"Lancet Infect Dis"},{"key":"3_CR148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2005.03.017","volume":"111","author":"CE Rupprecht","year":"2005","unstructured":"Rupprecht CE, Hanlon CA, Blanton J, Manangan J, Morrill P, Murphy S, Niezgoda M, Orciari LA, Schumacher CL, Dietzschold B (2005) Oral vaccination of dogs with recombinant rabies virus vaccines. Virus Res 111:101\u2013105","journal-title":"Virus Res"},{"key":"3_CR149","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.vaccine.2004.08.001","volume":"23","author":"G Sampath","year":"2005","unstructured":"Sampath G, Reddy SV, Rao ML, Rao YU, Palaniappan C (2005) An immunogenicity study of a newly introduced purified Vero cell rabies vaccine (Abhayrab) manufactured in India. Vaccine 23:897\u2013900","journal-title":"Vaccine"},{"key":"3_CR150","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","volume":"84","author":"CL Schumacher","year":"1989","unstructured":"Schumacher CL, Dietzschold B, Ertl HC, Niu HS, Rupprecht CE, Koprowski H (1989) Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. J Clin Invest 84:971\u2013975","journal-title":"J Clin Invest"},{"key":"3_CR151","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0264-410X(03)00559-0","volume":"22","author":"A Servat","year":"2003","unstructured":"Servat A, Lutsch C, Delore V, Lang J, Veitch K, Cliquet F (2003) Efficacy of rabies immunoglobulins in an experimental post-exposure prophylaxis rodent model. Vaccine 22: 244\u2013249","journal-title":"Vaccine"},{"key":"3_CR152","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(75)90130-0","volume":"2","author":"U Shah","year":"1975","unstructured":"Shah U, Jaswal GS (1975) Follow-up of rabid dog bite victims. Lancet 2:653\u2013655","journal-title":"Lancet"},{"key":"3_CR153","first-page":"66","volume":"37","author":"RA Shetty","year":"2005","unstructured":"Shetty RA, Chaturvedi S, Singh Z (2005) Profile of animal bite cases in Pune. J Commun Dis 37:66\u201372","journal-title":"J Commun Dis"},{"key":"3_CR154","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/hyb.1994.13.9","volume":"13","author":"K Siemoneit","year":"1994","unstructured":"Siemoneit K, da Silva Cardoso M, Wolpl A, Koerner K, Subanek B (1994) Isolation and epitope characterization of human monoclonal antibodies to hepatitis C virus core antigen. Hybridoma 13:9\u201313","journal-title":"Hybridoma"},{"key":"3_CR155","first-page":"1491","volume":"159","author":"RK Sikes","year":"1971","unstructured":"Sikes RK, Peacock GV, Acha P, Arko RJ, Dierks R (1971) Rabies vaccines: duration-of-immunity study in dogs. J Am Vet Med Assoc 159:1491\u20131499","journal-title":"J Am Vet Med Assoc"},{"key":"3_CR156","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ije\/16.4.602","volume":"16","author":"C Sitthi-Amorn","year":"1987","unstructured":"Sitthi-Amorn C, Jiratanavattana V, Keoyoo J, Sonpunya N (1987) The diagnostic properties of laboratory tests for rabies. Int J Epidemiol 16:602\u2013605","journal-title":"Int J Epidemiol"},{"key":"3_CR157","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/CDLI.1.6.613-619.1994","volume":"1","author":"HB Slade","year":"1994","unstructured":"Slade HB (1994) Human immunoglobulins for intravenous use and hepatitis C viral transmission. Clin Diagn Lab Immunol 1:613\u2013619","journal-title":"Clin Diagn Lab Immunol"},{"key":"3_CR158","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM199101243240401","volume":"324","author":"JS Smith","year":"1991","unstructured":"Smith JS, Fishbein DB, Rupprecht CE, Clark K (1991) Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med 324:205\u2013211","journal-title":"N Engl J Med"},{"key":"3_CR159","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0147-9571(82)90031-5","volume":"5","author":"F Steck","year":"1982","unstructured":"Steck F, Wandeler A, Bichsel P, Capt S, Hafliger U, Schneider L (1982) Oral immunization of foxes against rabies. Laboratory and field studies. Comp Immunol Microbiol Infect Dis 5:165\u2013171","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"4","key":"3_CR160","doi-asserted-by":"crossref","first-page":"S585","DOI":"10.1093\/clinids\/10.Supplement_4.S585","volume":"10","author":"JH Steele","year":"1988","unstructured":"Steele JH (1988) Rabies in the Americas and remarks on global aspects. Rev Infect Dis 10 [Suppl 4]:S585\u2013597","journal-title":"Rev Infect Dis"},{"key":"3_CR161","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2174\/1381612054367535","volume":"11","author":"E Stoger","year":"2005","unstructured":"Stoger E, Sack M, Nicholson L, Fischer R, Christou P (2005) Recent progress in plantibody technology. Curr Pharm Des 11:2439\u20132457","journal-title":"Curr Pharm Des"},{"key":"3_CR162","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/vr.139.2.32","volume":"139","author":"K Stohr","year":"1996","unstructured":"Stohr K, Meslin FM (1996) Progress and setbacks in the oral immunisation of foxes against rabies in Europe. Vet Rec 139:32\u201335","journal-title":"Vet Rec"},{"key":"3_CR163","first-page":"1023","volume":"25","author":"A Strady","year":"1996","unstructured":"Strady A, Lang J, Rotivel Y, Jaussaud R, Fritzell C, Tsiang H (1996) [Immunoprophylaxis of rabies: current recommendations]. Presse Med 25:1023\u20131027","journal-title":"Presse Med"},{"key":"3_CR164","first-page":"245","volume":"33","author":"MK Sudarshan","year":"2001","unstructured":"Sudarshan MK, Mahendra BJ, Narayan DH (2001) A community survey of dog bites, anti-rabies treatment, rabies and dog population management in Bangalore city. J Commun Dis 33:245\u2013251","journal-title":"J Commun Dis"},{"key":"3_CR165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","volume":"11","author":"MK Sudarshan","year":"2007","unstructured":"Sudarshan MK, Madhusudana SN, Mahendra BJ, Rao NS, Ashwath Narayana DH, Abdul Rahman S, Meslin FX, Lobo D, Ravikumar K, Gangaboraiah (2007) Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis 11:29\u201335","journal-title":"Int J Infect Dis"},{"key":"3_CR166","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0264-410X(94)90308-5","volume":"12","author":"P Suntharasamai","year":"1994","unstructured":"Suntharasamai P, Chaiprasithikul P, Wasi C, Supanaranond W, Auewarakul P, Chanthavanich P, Supapochana A, Areeraksa S, Chittamas S, Jittapalapongsa S, et al (1994) A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis. Vaccine 12:508\u2013512","journal-title":"Vaccine"},{"key":"3_CR167","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0035-9203(88)90167-8","volume":"82","author":"W Swaddiwuthipong","year":"1988","unstructured":"Swaddiwuthipong W, Weniger BG, Wattanasri S, Warrell MJ (1988) A high rate of neurological complications following Semple anti-rabies vaccine. Trans R Soc Trop Med Hyg 82: 472\u2013475","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3_CR168","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1098\/rstb.2001.0888","volume":"356","author":"LH Taylor","year":"2001","unstructured":"Taylor LH, Latham SM, Woolhouse ME (2001) Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 356:983\u2013989","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3_CR169","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0264-410X(91)90270-G","volume":"9","author":"M Tollis","year":"1991","unstructured":"Tollis M, Dietzschold B, Volia CB, Koprowski H (1991) Immunization of monkeys with rabies ribonucleoprotein (RNP) confers protective immunity against rabies. Vaccine 9:134\u2013136","journal-title":"Vaccine"},{"key":"3_CR170","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1073\/pnas.83.11.3914","volume":"83","author":"N Tordo","year":"1986","unstructured":"Tordo N, Poch O, Ermine A, Keith G, Rougeon F (1986) Walking along the rabies genome: is the large G-L intergenic region a remnant gene? Proc Natl Acad Sci U S A 83:3914\u20133918","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR171","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jbiotec.2005.07.018","volume":"121","author":"K Trabelsi","year":"2006","unstructured":"Trabelsi K, Rourou S, Loukil H, Majoul S, Kallel H (2006) Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. J Biotechnol 121:261\u2013271","journal-title":"J Biotechnol"},{"key":"3_CR172","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.171.1.19","volume":"171","author":"Y Ueki","year":"1990","unstructured":"Ueki Y, Goldfarb IS, Harindranath N, Gore M, Koprowski H, Notkins AL, Casali P (1990) Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus. J Exp Med 171:19\u201334","journal-title":"J Exp Med"},{"key":"3_CR173","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nri780","volume":"2","author":"JB Ulmer","year":"2002","unstructured":"Ulmer JB, Liu MA (2002) Ethical issues for vaccines and immunization. Nat Rev Immunol 2:291\u2013296","journal-title":"Nat Rev Immunol"},{"key":"3_CR174","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virusres.2005.03.007","volume":"111","author":"A Velasco-Villa","year":"2005","unstructured":"Velasco-Villa A, Orciari LA, Souza V, Juarez-Islas V, Gomez-Sierra M, Castillo A, Flisser A, Rupprecht CE (2005) Molecular epizootiology of rabies associated with terrestrial carnivores in Mexico. Virus Res 111:13\u201327","journal-title":"Virus Res"},{"key":"3_CR175","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/JCM.44.5.1697-1710.2006","volume":"44","author":"A Velasco-Villa","year":"2006","unstructured":"Velasco-Villa A, Orciari LA, Juarez-Islas V, Gomez-Sierra M, Padilla-Medina I, Flisser A, Souza V, Castillo A, Franka R, Escalante-Mane M, Sauri-Gonzalez I, Rupprecht CE (2006) Molecular diversity of rabies viruses associated with bats in Mexico and other countries of the Americas. J Clin Microbiol 44:1697\u20131710","journal-title":"J Clin Microbiol"},{"key":"3_CR176","first-page":"201","volume-title":"Historical perspective of rabies in Europe and the Mediterranean basin","author":"A Wandeler","year":"2004","unstructured":"Wandeler A (2004) Epidemiology and ecology of fox rabies in Europe. In: King AA, Fooks AR, Aubert M, Wandeler A (eds) Historical perspective of rabies in Europe and the Mediterranean basin. OIE, Paris, pp 201\u2013214"},{"issue":"4","key":"3_CR177","doi-asserted-by":"crossref","first-page":"S684","DOI":"10.1093\/clinids\/10.Supplement_4.S684","volume":"10","author":"AI Wandeler","year":"1988","unstructured":"Wandeler AI, Budde A, Capt S, Kappeler A, Matter H (1988) Dog ecology and dog rabies control. Rev Infect Dis 10 [Suppl 4]:S684\u2013S688","journal-title":"Rev Infect Dis"},{"key":"3_CR178","doi-asserted-by":"crossref","first-page":"51","DOI":"10.20506\/rst.12.1.663","volume":"12","author":"AI Wandeler","year":"1993","unstructured":"Wandeler AI, Matter HC, Kappeler A, Budde A (1993) The ecology of dogs and canine rabies: a selective review. Rev Sci Tech 12:51\u201371","journal-title":"Rev Sci Tech"},{"key":"3_CR179","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/viro.1996.8384","volume":"228","author":"Y Wang","year":"1997","unstructured":"Wang Y, Xiang Z, Pasquini S, Ertl HC (1997) Immune response to neonatal genetic immunization. Virology 228:278\u2013284","journal-title":"Virology"},{"key":"3_CR180","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1128\/JVI.72.3.1790-1796.1998","volume":"72","author":"Y Wang","year":"1998","unstructured":"Wang Y, Xiang Z, Pasquini S, Ertl HC (1998) Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus. J Virol 72:1790\u20131796","journal-title":"J Virol"},{"key":"3_CR181","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(85)92367-0","volume":"1","author":"MJ Warrell","year":"1985","unstructured":"Warrell MJ, Nicholson KG, Warrell DA, Suntharasamai P, Chanthavanich P, Viravan C, Sinhaseni A, Chiewbambroongkiat MK, Pouradier-Duteil X, Xueref C, et al (1985) Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1:1059\u20131062","journal-title":"Lancet"},{"key":"3_CR182","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1042\/bst0220940","volume":"22","author":"GC Whitelam","year":"1994","unstructured":"Whitelam GC, Cockburn W, Owen MR (1994) Antibody production in transgenic plants. Biochem Soc Trans 22:940\u2013944","journal-title":"Biochem Soc Trans"},{"key":"3_CR183","unstructured":"WHO (1993) Report of the fourth WHO consultation on oral immunization of dogs against rabies. WHO, Geneva. http:\/\/www.who.int\/rabies\/animal\/en\/whorabres9342.pdf . Cited 18 May 2007"},{"key":"3_CR184","unstructured":"WHO (1996) WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization. WHO, Geneva. http:\/\/whqlibdoc.who.int\/hq\/1996\/WHO_EMC_ZOO_96.6.pdf . Cited 18 May 2007"},{"key":"3_CR185","unstructured":"WHO (1998) World survey of rabies N\u00b0 32 for the Year 1996. WHO, Geneva. http:\/\/whqlibdoc.who.int\/hq\/1998\/WHO_EMC_ZDI_98.4.pdf . Cited 18 May 2007"},{"key":"3_CR186","unstructured":"WHO (2001) Strategies for the control and elimination of rabies in Asia. WHO, Geneva. http:\/\/www.who.int\/rabies\/en\/Strategies_for_the_control_and_elimination_of_rabies_in_Asia.pdf . Cited 18 May 2007"},{"key":"3_CR187","first-page":"109","volume":"77","author":"WHO","year":"2002","unstructured":"WHO (2002a) Rabies vaccines. Wkly Epidemiol Rec 77:109\u2013119","journal-title":"Wkly Epidemiol Rec"},{"key":"3_CR188","unstructured":"WHO (2002b) World Survey of Rabies N\u00b0 35 for the Year 1999. WHO, Geneva. http:\/\/www.who.int\/rabies\/resources\/wsr1999\/en\/index.html . Cited 18 May 2007"},{"key":"3_CR189","series-title":"First report, WHO technical report series 931","first-page":"121","volume-title":"WHO expert consultation on rabies","author":"WHO","year":"2004","unstructured":"WHO (2004) WHO expert consultation on rabies. First report, WHO technical report series 931. WHO, Geneva, p 121"},{"key":"3_CR190","unstructured":"WHO (2006) Rabies fact sheet N\u00b0 99. WHO, Geneva. http:\/\/www.who.int\/mediacentre\/factsheets\/fs099\/en\/print.html . Cited 18 May 2007"},{"key":"3_CR191","unstructured":"WHO-APCRI (2004) Assessing burden of rabies in India. WHO, Geneva. http:\/\/www.apcri.org\/whosurvey.pdf . Cited 18 May 2007"},{"key":"3_CR192","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1073\/pnas.75.8.3938","volume":"75","author":"TJ Wiktor","year":"1978","unstructured":"Wiktor TJ, Koprowski H (1978) Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants. Proc Natl Acad Sci U S A 75:3938\u20133942","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR193","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3181\/00379727-131-33981","volume":"131","author":"TJ Wiktor","year":"1969","unstructured":"Wiktor TJ, Sokol F, Kuwert E, Koprowski H (1969) Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin. Proc Soc Exp Biol Med 131:799\u2013805","journal-title":"Proc Soc Exp Biol Med"},{"key":"3_CR194","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0264-410X(89)90010-8","volume":"7","author":"H Wilde","year":"1989","unstructured":"Wilde H, Choomkasien P, Hemachudha T, Supich C, Chutivongse S (1989) Failure of rabies postexposure treatment in Thailand. Vaccine 7:49\u201352","journal-title":"Vaccine"},{"key":"3_CR195","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinids\/22.2.228","volume":"22","author":"H Wilde","year":"1996","unstructured":"Wilde H, Sirikawin S, Sabcharoen A, Kingnate D, Tantawichien T, Harischandra PA, Chaiyabutr N, de Silva DG, Fernando L, Liyanage JB, Sitprija V (1996) Failure of postexposure treatment of rabies in children. Clin Infect Dis 22:228\u2013232","journal-title":"Clin Infect Dis"},{"key":"3_CR196","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/324628","volume":"34","author":"H Wilde","year":"2002","unstructured":"Wilde H, Khawplod P, Hemachudha T, Sitprija V (2002) Postexposure treatment of rabies infection: can it be done without immunoglobulin? Clin Infect Dis 34:477\u2013480","journal-title":"Clin Infect Dis"},{"key":"3_CR197","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.vaccine.2005.01.030","volume":"23","author":"H Wilde","year":"2005","unstructured":"Wilde H, Khawplod P, Khamoltham T, Hemachudha T, Tepsumethanon V, Lumlerdacha B, Mitmoonpitak C, Sitprija V (2005) Rabies control in South and Southeast Asia. Vaccine 23:2284\u20132289","journal-title":"Vaccine"},{"key":"3_CR198","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1056\/NEJMoa050382","volume":"352","author":"RE Willoughby Jr","year":"2005","unstructured":"Willoughby RE Jr, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, Chusid MJ, Rupprecht CE (2005) Survival after treatment of rabies with induction of coma. N Engl J Med 352:2508\u20132514","journal-title":"N Engl J Med"},{"key":"3_CR199","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/scientificamerican0692-86","volume":"266","author":"WG Winkler","year":"1992","unstructured":"Winkler WG, Bogel K (1992) Control of rabies in wildlife. Sci Am 266:86\u201392","journal-title":"Sci Am"},{"key":"3_CR200","first-page":"23","volume-title":"Rabies","author":"WH Wunner","year":"2002","unstructured":"Wunner WH (2002) Rabies virus. In: Jackson AC, Wunner WH (eds) Rabies. Academic Press, San Diego, pp 23\u201377"},{"issue":"4","key":"3_CR201","doi-asserted-by":"crossref","first-page":"S771","DOI":"10.1093\/clinids\/10.Supplement_4.S771","volume":"10","author":"WH Wunner","year":"1988","unstructured":"Wunner WH, Larson JK, Dietzschold B, Smith CL (1988) The molecular biology of rabies viruses. Rev Infect Dis 10 [Suppl 4]:S771\u2013S784","journal-title":"Rev Infect Dis"},{"key":"3_CR202","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1994.1105","volume":"199","author":"ZQ Xiang","year":"1994","unstructured":"Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132\u2013140","journal-title":"Virology"},{"key":"3_CR203","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/viro.1995.1289","volume":"209","author":"ZQ Xiang","year":"1995","unstructured":"Xiang ZQ, Spitalnik SL, Cheng J, Erikson J, Wojczyk B, Ertl HC (1995) Immune responses to nucleic acid vaccines to rabies virus. Virology 209:569\u2013579","journal-title":"Virology"},{"key":"3_CR204","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1016\/S0264-410X(02)00260-8","volume":"20","author":"V Yusibov","year":"2002","unstructured":"Yusibov V, Hooper DC, Spitsin SV, Fleysh N, Kean RB, Mikheeva T, Deka D, Karasev A, Cox S, Randall J, Koprowski H (2002) Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 20:3155\u20133164","journal-title":"Vaccine"}],"container-title":["Current Topics in Microbiology and Immunology","Human Antibody Therapeutics for Viral Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-72146-8_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T10:20:16Z","timestamp":1708338016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-72146-8_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"ISBN":["9783540721444","9783540721468"],"references-count":204,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-72146-8_3","relation":{},"ISSN":["0070-217X"],"issn-type":[{"value":"0070-217X","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}